Shanghai, China

Dengning Xia

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Georgia Tech Research Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dengning Xia. Retrieved from https://idiyas.com/inventor/dengning-xia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dengning Xia

Introduction: Dengning Xia is an inventor based in Shanghai, China, who is currently associated with the Georgia Tech Research Corporation. He has made significant contributions to the field of drug delivery systems, focusing on innovative methods to enhance the efficacy of treatments.

Latest Patent Applications: Dengning Xia has filed a patent application titled "Devices, Systems, and Methods for Facilitating Tissue Delivery of Drug." This application describes devices and methods for administering drugs to biological tissues in patients, utilizing intracellular and dermal delivery techniques. The device includes a piezoelectric pulse generator and an array of microneedle electrodes that are electrically coupled to the generator. Upon insertion into biological tissue, the device generates and delivers electrical pulses through the microneedle electrodes, effectively electroporating cells and enabling drug delivery into the electroporated cells.

Conclusion: Dengning Xia's work in developing advanced drug delivery systems showcases his commitment to innovation in the medical field. His contributions have the potential to significantly improve patient outcomes through more effective treatment methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…